SNX-281

N/A

Report date: 2024/04/01 14:31:13
NME

Base Information

Drug NameSNX-281
Drug Alias NameSTING agonist (Silicon Therapeutics)SNX-281
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionStimulator of interferon genes stimulants
TargetsStimulator of interferon genes
Therapy Area/IndicationsSolid tumoursLymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSilicon Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesStingthera Inc
Active IndicationsSolid tumoursLymphoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A